Article Text

Download PDFPDF
Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.
  1. K Fujiwara,
  2. I Ogata,
  3. Y Ohta,
  4. K Hirata,
  5. Y Oka,
  6. S Yamada,
  7. Y Sato,
  8. N Masaki,
  9. H Oka
  1. First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.


    Liver damage was induced in rats by injection of dimethylnitrosamine (DMN) or carbon tetrachloride (CCl4). Fibrin clots were observed in the hepatic sinusoids at 12 hours and soluble fibrin monomer complexes were markedly detected at 24 hours only in the rats given DMN. When antithrombin III concentrate was infused at 12 hours there was a dose dependent improvement of the values of serum total bilirubin, SGPT, prothrombin time, peripheral platelet count, and plasma fibrinogen and coagulation factor VIIIC and of the histological degree of liver injury at 24 hours in the DMN group. The CCl4-group showed no such improvement. Intravascular coagulation may complicate the course of certain types of acute liver injury and contribute to its aggravation in rats. Under such circumstances, treatment with antithrombin III concentrate would be beneficial.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.